<unk> 's current use is mainly in chronic lymphocytic leukemia, as it is well tolerated by most patients, though<unk>  has been largely replaced by fludarabine as first-line treatment in younger patients. It can be used for treating some types of non-Hodgkin lymphoma, Waldenström macroglobulinemia, polycythemia vera, trophoblastic neoplasms, and ovarian carcinoma. Moreover, it also has been used as an immunosuppressive drug for various autoimmune and inflammatory conditions, such as nephrotic syndrome.
Chlorambucil
Tioguanine
Indolocarbazole
Periciazine
Hydroxycarbamide
Vindesine
Tipiracil
Milbemycin